Illinois General Assembly - Bill Status for HB3533
Illinois General Assembly

  Bills & Resolutions  
  Compiled Statutes  
  Public Acts  
  Legislative Reports  
  IL Constitution  
  Legislative Guide  
  Legislative Glossary  

 Search By Number
 (example: HB0001)
Search Tips

Search By Keyword

 Bill Status of HB3533  102nd General Assembly


Short Description:  NALOXONE INFORMATION

House Sponsors
Rep. Deb Conroy and Kambium Buckner

Last Action
DateChamber Action
  4/23/2021HouseRule 19(a) / Re-referred to Rules Committee

Statutes Amended In Order of Appearance
720 ILCS 570/316.5 new


Synopsis As Introduced
Amends the Illinois Controlled Substances Act. Provides that a prescriber shall provide information to all patients receiving a prescription for opioids on overdose prevention and the use of naloxone hydrochloride or another drug approved by the United States Food and Drug Administration for the complete or partial reversal of opioid depression.

Actions 
DateChamber Action
  2/19/2021HouseFiled with the Clerk by Rep. Deb Conroy
  2/22/2021HouseFirst Reading
  2/22/2021HouseReferred to Rules Committee
  3/11/2021HouseAdded Co-Sponsor Rep. Kambium Buckner
  3/16/2021HouseAssigned to Mental Health & Addiction Committee
  3/26/2021HouseDo Pass / Short Debate Mental Health & Addiction Committee; 016-000-000
  4/8/2021HousePlaced on Calendar 2nd Reading - Short Debate
  4/21/2021HouseSecond Reading - Short Debate
  4/21/2021HouseHeld on Calendar Order of Second Reading - Short Debate
  4/23/2021HouseRule 19(a) / Re-referred to Rules Committee

Back To Top